• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

Melanoma antigens create new therapies

San Francisco - Molecular definition of cancer antigens has opened new possibilities for developing effective adjuvant melanoma immunotherapies, according to Steven A. Rosenberg, M.D., Ph.D.

Related Videos
Related Content
Key Insights From the SPD Pre-AAD Meeting: Advances, Challenges, and the Future of Pediatric Dermatology
March 25th 2025

Key Insights From the SPD Pre-AAD Meeting: Advances, Challenges, and the Future of Pediatric Dermatology

The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
August 1st 2023

The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis

Insights From the ADORING 3 Study and Tapinarof’s Treatment-Free Periods in AD
March 8th 2025

Insights From the ADORING 3 Study and Tapinarof’s Treatment-Free Periods in AD

The Cutaneous Connection
August 5th 2021

The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma

FDA Accepts Supplemental New Drug Application for Arcutis’ Roflumilast in Children with AD
February 26th 2025

FDA Accepts Supplemental New Drug Application for Arcutis’ Roflumilast in Children with AD

Reviewing Complex Cases: Topicals for Pediatric AD
February 25th 2025

Reviewing Complex Cases: Topicals for Pediatric AD

© 2025 MJH Life Sciences

All rights reserved.